This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: cancer immunotherapies
The EuroNanoMedIII project 2-INTRATARGET Develops Nano-Immunotherapeutics for the Intracellular targeting of Cancer Cells and Tumor Associated Macrophages
June 15, 2018This public-private European Consortium will develop new nanostructures to deliver selected cancer immunotherapies, such as polynucleotides, to their intracellular targets inside cancer cells and into tumor associated macrophages (TAMs), both at the primary tumor site and in their metastatic niches
Read More